clarithromycin has been researched along with Hyperlipemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arias, M; Rodrigo, E; Valero, R; Zubimendi, JA | 1 |
| Emmett, L; Perera, C; Thanakrishnan, K; Trieu, J; Van Der Wall, H | 1 |
| Lee, AJ; Maddix, DS | 1 |
1 review(s) available for clarithromycin and Hyperlipemia
| Article | Year |
|---|---|
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Rhabdomyolysis; Simvastatin; Sinusitis | 2001 |
2 other study(ies) available for clarithromycin and Hyperlipemia
| Article | Year |
|---|---|
[Rhabdomyolysis secondary to the interaction of statins with macrolides in a renal transplant patient].
Topics: Aged; Anticholesteremic Agents; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Hyperlipidemias; Inactivation, Metabolic; Kidney Transplantation; Male; Postoperative Complications; Respiratory Tract Infections; Rhabdomyolysis; Simvastatin | 2004 |
Rhabdomyolysis resulting from interaction of simvastatin and clarithromycin demonstrated by Tc-99m MDP scintigraphy.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Radionuclide Imaging; Radiopharmaceuticals; Respiratory Tract Infections; Rhabdomyolysis; Simvastatin; Technetium Tc 99m Medronate | 2004 |